• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Smith+Nephew acquires cementless partial knee maker Engage Surgical

Smith+Nephew acquires cementless partial knee maker Engage Surgical

January 19, 2022 By Sean Whooley

Engage Surgical Smith+Nephew cementless partial knee system
Engage Surgical’s partial knee system. [Image from Engage Surgical]
Smith+Nephew (NYSE:SNN) announced today that it acquired Engage Surgical and its cementless unicompartmental (partial) knee system.

The total cost of the acquisition will reach up to $135 million, contingent on sales performance. Smith+Nephew funded the acquisition from existing cash and debt facilities.

Orlando, Florida–based Engage Surgical designed its partial knee system as a novel, modern, cementless knee implant aiming at seizing the potential for better long-term fixation through biologic integration, shorter operating times and a shift to ambulatory surgery centers (ASCs).

The company’s platform is the only cementless unicompartmental knee system commercially available in the U.S., according to a news release.

London-based Smith+Nephew said the acquisition supports its growth strategy while providing differentiation for its customers.

“Smith+Nephew is now the only medical device company offering both cemented and cementless partial knee implants in the U.S., as well as robotics assistance through the Cori surgical system that is well-suited for the precise alignment needed,” said Randy Kilburn, Smith+Nephew EVP & GM of Reconstruction, Robotics & Digital.

Kilburn said in the release: “Through our sports medicine franchise, we have an established, strong position in ASCs where the vast majority of partial knees in the U.S. are performed. Our Visionaire business, the high performance and small footprint of Cori, plus our partial knee portfolio, is a uniquely compelling offering for customers.”

The company said Engage’s system is optimized for robotics and will have an application with the Cori system in the future while also complementing Smith+Nephew’s focus on serving the growing outpatient market and driving market expansion in the U.S., among other markets.

“The Engage Surgical team is excited about joining Smith+Nephew to help expand the impact of the Engage Surgical partial knee system and integrating it with the Cori surgical system,” Engage Surgical CEO Dan Justin said. “Smith+Nephew is well-suited and well-prepared to continue our mission of providing better outcomes for knee arthroplasty patients.”

Filed Under: Business/Financial News, Featured, Implants, Mergers & Acquisitions, News Well, Orthopedics Tagged With: Engage Surgical, Smith+Nephew

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy